Celltrion Pharm

068760.KQ

37.19 USD

-0.57

-1.51%

Overview

Last close

37.19 usd

Market cap

1.65B usd

52 week high

52.45 usd

52 week low

30.18 usd

Target price

91.47 usd

Valuation

P/E

N/A

Forward P/E

49.505

Price/Sales

8.9805

Price/Book Value

5.6897

Enterprise Value

1.70B usd

EV/Revenue

4.7071

EV/EBITDA

32.1113

Key financials

Revenue TTM

184.77M usd

Gross Profit TTM

54.37M usd

EBITDA TTM

28.78M usd

Earnings per Share

N/A usd

Dividend

0.13 usd

Total assets

526.39M usd

Net debt

63.86M usd

About

Celltrion Pharm, Inc., a pharmaceutical company, develops and sells biosimilars and over-the-counter drugs in South Korea. The company offers hepatotonic, anti-inflammatory, antihistamine, respiratory apparatus, circulary system, digestive and stomachic, hormone/metabolic disease, antibiotic/antimycotic, nutrientia and tonic, immunology, oncology, and other drugs. It serves university hospitals and general pharmacies. Celltrion Pharm Inc. was founded in 1976 and is based in Cheongju-si, South Korea. Celltrion Pharm, Inc. (KOSDAQ:A068760) operates as a subsidiary of Celltrion, Inc.